The Royal Marsden NHS Foundation Trust at FoG London 2027
Jan 27–28, 2027 London, UK ~8.3k attendees Website
The Royal Marsden NHS Foundation Trust takes part in 2 sessions at FoG London 2027 in London, its home city. Its sessions cover how to get the most patient benefit from cancer genomics at a cost the NHS can afford. The most concrete topic is how to use circulating tumour DNA testing for minimal residual disease in colorectal cancer today.
| Organization | FoG London 2027 Attendance |
|---|---|
The Royal Marsden NHS Foundation Trust London, UK | |
Specialist NHS cancer hospital with sites in Chelsea and Sutton, partnered with the Institute of Cancer Research. | Talk Wed Jan 27 11:30–12:00 How Can Cancer Genomics Be Optimised To Maximise Patient Benefit Without Bankrupting The NHS? How health economics can match cancer genomic tests to the right delivery models so patients benefit without overstretching NHS budgets. Talk Wed Jan 27 17:30–18:00 From Prognosis to Practice: How Should We Use ctDNA-Guided MRD Testing in Colorectal Cancer Today? What blood tests for tumour DNA left after treatment can reliably show in colorectal cancer today, and how that differs between disease stages. |
Find decision makers at The Royal Marsden NHS Foundation Trust
Tell us what you sell and we’ll find the people at The Royal Marsden NHS Foundation Trust most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction